Ex) Article Title, Author, Keywords
pISSN 1598-298X
eISSN 2384-0749
Ex) Article Title, Author, Keywords
J Vet Clin 2022; 39(5): 253-257
https://doi.org/10.17555/jvc.2022.39.5.253
Published online October 31, 2022
Sangjun Oh , Jinsu Kang , Bumseok Kim , Namsoo Kim , Suyoung Heo*
Correspondence to:*syheo@jbnu.ac.kr
Copyright © The Korean Society of Veterinary Clinics.
A 5-year-old castrated male Golden Retriever dog weighing 15 kg presented with evidence of intestinal intussusception. The patient had cachexia and severe dehydration before being referred to our department. Ultrasound imaging revealed a target sign indicative of intestinal intussusception. Emergency surgery was performed shortly after diagnosis. After a successful surgery, the patient was hospitalised for postoperative care. Initial treatment was aimed at the reversion of dehydration and the provision of adequate nutrition. Fluid therapy and central parenteral nutrition were administered via the peripheral and central venous catheters, respectively. Ten days postoperatively, swelling and edema were observed in the head and neck. Ultrasound and computed tomography confirmed complete blockage of the cranial vena cava due to thrombosis, which consequently obstructed both the left and right jugular veins. For treatment, dalteparin and tissue plasminogen activator were administered. However, the patient lost all of its vital function on the daybreak of postoperative day 11. Venous thrombus formation secondary to central parenteral nutrition application via the central line is a rare but possible complication. Veterinarians who are concerned about taking care of patients receiving CPN through the central line should keep the possibility of venous thrombus formation in mind.
Keywords: central parenteral nutrition, jugular thrombosis, central line, cranial vena cava syndrome, Virchow's triad.
Cranial vena cava syndrome refers to the constellation of clinical signs resulting from the partial or complete obstruction of the cranial vena cava (2). There are numerous causes of cranial vena cava syndrome, such as thrombus, neoplasia, and granuloma (2). These factors pose a high risk of obstruction in the cranial vena cava, resulting in edema of the head, neck, and forelimb, and, occasionally, pleural effusion.
Among several causes, thrombus formation can be described by what is called Virchow’s triad. Virchow’s triad comprises three broad categories of mechanisms underlying thrombosis (1). These are endothelial damage, abnormal blood flow, and hypercoagulability (10). They may be independent or interact with each other to form a thrombus. The causes of endothelial damage include sepsis, intravenous catheterisation, disseminated intravascular coagulation and heartworm injury. The causes of abnormal blood flow include local stasis, reduced blood flow, cardiac disease, hypovolemia, and heartworm injury. The causes of hypercoagulability include DIC, pancreatitis, sepsis, and infection (6).
This report reviews the case of cranial vena cava syndrome associated with the administration of CPN through the central line and assesses the risk of cranial vena cava syndrome when applying CPN.
A 5-year-old castrated male Golden Retriever dog weighing 15 kg was presented at Jeonbuk Animal Medical Center (Jeonbuk National University, College of Veterinary Medicine, Jeollabukdo, Korea) with evidence of intestinal intussusception. He had a history of heartworm infection and was severely cachectic and dehydrated before his referral to our department. Further physical examination and blood work revealed lethargy, acidemia, and hypoproteinemia.
Ultrasonography of the abdomen (Aplio 300, Canon Medical Systems; Tokyo, Japan) with a linear-array probe (12 MHz) confirmed ascites and a target sign located at the jejunum (suspected), which is indicative of intestinal intussusception (Fig. 1). Shortly after diagnosis, emergency surgery was performed using the enteroplication method. After successful surgery, the patient was hospitalised for postoperative care. Initial treatment was aimed at the reversion of dehydration and the provision of adequate nutrition. Fluid therapy (crystalloid 12 mL/kg/hr, colloid 1 mL/kg/hr, butorphanol-Lidocaine-Ketamine 2 mL/kg/hr) and central parenteral nutrition (60 mL/h, 1116 mOsmol/L) were administered via peripheral and central venous catheters, respectively.
On the second postoperative day, the serum albumin and total protein concentrations were low, with a serum albumin concentration of 1.6 g/dL. Low perioperative serum albumin is known to be a poor prognostic factor for intestinal healing (7); therefore, albumin was supplemented with 20% human albumin (SK human albumin, SK plasma; Seongnam, Korea) diluted to 10%. On the following day, the serum albumin concentration immediately increased to 2.9 g/dL. From the second day, however, serum albumin decreased to 1.9 g/dL and remained constant at low concentrations.
Ten days postoperatively, swelling and edema were observed in the head and neck. Ultrasonographic Doppler scan of the jugular region showed an absence of blood flow in both jugular veins (Fig. 2). An additional CT scan (Alexion TSX-034A, Canon Medical Systems; Tokyo, Japan) and angiography using a non-ionic iodine contrast medium (iohexol, Omnipaque 300, GE healthcare; Illinois Chicago, USA) were performed, and a complete blockage of the cranial vena cava was diagnosed by confirming the absence of contrast media cranial to the heart (Fig. 3). Anticoagulant (Dalteparin sodium, Fragmin, 2500 IU/mL, Pfizer, New York, USA) was administered (100 U/kg, SC, tid) and thrombolytic (recombinant tissue plasminogen activator, Actilyse, 20 mg; Boehringer Ingelheim, Ingelheim, Germany) treatments (0.4 mg/kg) were immediately administered, but the patient had completely lost all of its vital functions at daybreak on postoperative day 11.
Necropsy was performed the following day, and the thrombus was confirmed in the jugular vein, including a thickened endothelial wall and changes associated with endothelial damage. (Fig. 4) Histological samples obtained from necropsy showed a loss of endothelial cells and fibrosis secondary to inflammation. Evidence of recanalization was also observed, which proved the existence of vascular occlusion (Fig. 5). With a history of heartworm infection, we confirmed multiple heartworms through both necropsy and histological examination (Fig. 6). This finding supports the existence of endothelial damage.
In human medicine, the reported rate of central line complications associated with thrombus formation ranges from 14% to 18% (10). To the author’s knowledge, however, there are only a few reported cases in veterinary medicine. In veterinary medicine, various studies (2,5,9) have previously discussed issues related to cranial vena cava syndrome, but all three of their reports involved pacemaker implantation and no CPN application. Likewise, only a few studies in veterinary medicine have directly linked thrombus formation to a complication of CPN application.
Virchow’s triad refers to three major categories of mechanisms that interact to facilitate thrombus formation, and these are endothelial damage, abnormal blood flow, and hypercoagulability (1). Although several known causes fall within these three categories, it is unlikely that the alteration of any single component of the triad would be sufficient to induce thrombosis (3). Several factors have to interact to facilitate thrombus formation. Likewise, the patient in this report had severe cachexia, hypovolemic shock, and heartworm infection, which all fell within the criteria of Virchow’s triad and were considered to have contributed simultaneously to thrombus formation. Furthermore, all of these clinical states that have a negative influence on both prognosis and mortality led to the need for CPN administration and central line placement. All of these numerous negative factors, the characteristics of CPN, and the long-term use of CPN contributed to the consequent cranial vena cava syndrome.
Protein-losing enteropathy is one of the factors influencing Virchow’s triad. Although not the sole cause of protein-losing enteropathy the loss of antithrombin contributes to hypercoagulability (4). Protein-losing enteropathy was not definitively diagnosed in this study, but clinical signs and laboratory findings supported its existence and, therefore, is a potential contraindication for central line placement. However, parenteral feeding via a central venous catheter was necessary because the patient had anorexia and cachexia. The condition of the patient presented a clinical dilemma in deciding the placement of the central line, which can be a further consideration for clinicians confronted with similar situations.
In a retrospective study by Reuter et al. (8), the overall mortality rate of patients who had received CPN was 48.8%. Among the 209 dogs included in this study, 5% had jugular thrombosis and a mortality rate of 50%. Furthermore, in two studies previously mentioned in this report, all patients were euthanized because of their debilitating state and complications. From the data obtained from these reports, clinicians should acknowledge that the status of a patient requiring CPN application is associated with mortality rate, and close monitoring is important.
Limitation of this case report is that its number of case is not enough to provide any solid opinion. The patient showed several signs associated with thrombus formation caused by CPN application and, thus, cranial vena cava syndrome; however, it is insufficient to say that CPN application was the sole cause. Additional studies with larger sample sizes are required to verify their association. Furthermore, coagulation profile was not performed during hospitalization. Anticoagulant and thrombolytic treatments were given only after diagnosis of clinical sign and ultrasound findings. Therefore it is hard to say that treatment strategy was optimal.
In conclusion, venous thrombus formation secondary to CPN application via the central line is a rare but possible complication. Veterinarians who are concerned about taking care of patients receiving CPN through the central line should keep the possibility of venous thrombus formation in mind. Patients with concurrent hypercoagulability disease or protein-related disease are at greater risk of thrombus formation.
This research was financially supported by the Ministry of Small and Medium-sized Enterprises (SMEs) and Startups (MSS), Korea, under the “Regional Specialized Industry Development Plus Program (R&D, S3244754)” supervised by the Korea Technology and Information Promotion Agency (TIPA).
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No.2020R1F1A1075219).
The authors have no conflicting interests.
J Vet Clin 2022; 39(5): 253-257
Published online October 31, 2022 https://doi.org/10.17555/jvc.2022.39.5.253
Copyright © The Korean Society of Veterinary Clinics.
Sangjun Oh , Jinsu Kang , Bumseok Kim , Namsoo Kim , Suyoung Heo*
Department of Veterinary Surgery, College of Veterinary Medicine, Jeonbuk National University, Iksan 54596, Korea
Correspondence to:*syheo@jbnu.ac.kr
This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
A 5-year-old castrated male Golden Retriever dog weighing 15 kg presented with evidence of intestinal intussusception. The patient had cachexia and severe dehydration before being referred to our department. Ultrasound imaging revealed a target sign indicative of intestinal intussusception. Emergency surgery was performed shortly after diagnosis. After a successful surgery, the patient was hospitalised for postoperative care. Initial treatment was aimed at the reversion of dehydration and the provision of adequate nutrition. Fluid therapy and central parenteral nutrition were administered via the peripheral and central venous catheters, respectively. Ten days postoperatively, swelling and edema were observed in the head and neck. Ultrasound and computed tomography confirmed complete blockage of the cranial vena cava due to thrombosis, which consequently obstructed both the left and right jugular veins. For treatment, dalteparin and tissue plasminogen activator were administered. However, the patient lost all of its vital function on the daybreak of postoperative day 11. Venous thrombus formation secondary to central parenteral nutrition application via the central line is a rare but possible complication. Veterinarians who are concerned about taking care of patients receiving CPN through the central line should keep the possibility of venous thrombus formation in mind.
Keywords: central parenteral nutrition, jugular thrombosis, central line, cranial vena cava syndrome, Virchow's triad.
Cranial vena cava syndrome refers to the constellation of clinical signs resulting from the partial or complete obstruction of the cranial vena cava (2). There are numerous causes of cranial vena cava syndrome, such as thrombus, neoplasia, and granuloma (2). These factors pose a high risk of obstruction in the cranial vena cava, resulting in edema of the head, neck, and forelimb, and, occasionally, pleural effusion.
Among several causes, thrombus formation can be described by what is called Virchow’s triad. Virchow’s triad comprises three broad categories of mechanisms underlying thrombosis (1). These are endothelial damage, abnormal blood flow, and hypercoagulability (10). They may be independent or interact with each other to form a thrombus. The causes of endothelial damage include sepsis, intravenous catheterisation, disseminated intravascular coagulation and heartworm injury. The causes of abnormal blood flow include local stasis, reduced blood flow, cardiac disease, hypovolemia, and heartworm injury. The causes of hypercoagulability include DIC, pancreatitis, sepsis, and infection (6).
This report reviews the case of cranial vena cava syndrome associated with the administration of CPN through the central line and assesses the risk of cranial vena cava syndrome when applying CPN.
A 5-year-old castrated male Golden Retriever dog weighing 15 kg was presented at Jeonbuk Animal Medical Center (Jeonbuk National University, College of Veterinary Medicine, Jeollabukdo, Korea) with evidence of intestinal intussusception. He had a history of heartworm infection and was severely cachectic and dehydrated before his referral to our department. Further physical examination and blood work revealed lethargy, acidemia, and hypoproteinemia.
Ultrasonography of the abdomen (Aplio 300, Canon Medical Systems; Tokyo, Japan) with a linear-array probe (12 MHz) confirmed ascites and a target sign located at the jejunum (suspected), which is indicative of intestinal intussusception (Fig. 1). Shortly after diagnosis, emergency surgery was performed using the enteroplication method. After successful surgery, the patient was hospitalised for postoperative care. Initial treatment was aimed at the reversion of dehydration and the provision of adequate nutrition. Fluid therapy (crystalloid 12 mL/kg/hr, colloid 1 mL/kg/hr, butorphanol-Lidocaine-Ketamine 2 mL/kg/hr) and central parenteral nutrition (60 mL/h, 1116 mOsmol/L) were administered via peripheral and central venous catheters, respectively.
On the second postoperative day, the serum albumin and total protein concentrations were low, with a serum albumin concentration of 1.6 g/dL. Low perioperative serum albumin is known to be a poor prognostic factor for intestinal healing (7); therefore, albumin was supplemented with 20% human albumin (SK human albumin, SK plasma; Seongnam, Korea) diluted to 10%. On the following day, the serum albumin concentration immediately increased to 2.9 g/dL. From the second day, however, serum albumin decreased to 1.9 g/dL and remained constant at low concentrations.
Ten days postoperatively, swelling and edema were observed in the head and neck. Ultrasonographic Doppler scan of the jugular region showed an absence of blood flow in both jugular veins (Fig. 2). An additional CT scan (Alexion TSX-034A, Canon Medical Systems; Tokyo, Japan) and angiography using a non-ionic iodine contrast medium (iohexol, Omnipaque 300, GE healthcare; Illinois Chicago, USA) were performed, and a complete blockage of the cranial vena cava was diagnosed by confirming the absence of contrast media cranial to the heart (Fig. 3). Anticoagulant (Dalteparin sodium, Fragmin, 2500 IU/mL, Pfizer, New York, USA) was administered (100 U/kg, SC, tid) and thrombolytic (recombinant tissue plasminogen activator, Actilyse, 20 mg; Boehringer Ingelheim, Ingelheim, Germany) treatments (0.4 mg/kg) were immediately administered, but the patient had completely lost all of its vital functions at daybreak on postoperative day 11.
Necropsy was performed the following day, and the thrombus was confirmed in the jugular vein, including a thickened endothelial wall and changes associated with endothelial damage. (Fig. 4) Histological samples obtained from necropsy showed a loss of endothelial cells and fibrosis secondary to inflammation. Evidence of recanalization was also observed, which proved the existence of vascular occlusion (Fig. 5). With a history of heartworm infection, we confirmed multiple heartworms through both necropsy and histological examination (Fig. 6). This finding supports the existence of endothelial damage.
In human medicine, the reported rate of central line complications associated with thrombus formation ranges from 14% to 18% (10). To the author’s knowledge, however, there are only a few reported cases in veterinary medicine. In veterinary medicine, various studies (2,5,9) have previously discussed issues related to cranial vena cava syndrome, but all three of their reports involved pacemaker implantation and no CPN application. Likewise, only a few studies in veterinary medicine have directly linked thrombus formation to a complication of CPN application.
Virchow’s triad refers to three major categories of mechanisms that interact to facilitate thrombus formation, and these are endothelial damage, abnormal blood flow, and hypercoagulability (1). Although several known causes fall within these three categories, it is unlikely that the alteration of any single component of the triad would be sufficient to induce thrombosis (3). Several factors have to interact to facilitate thrombus formation. Likewise, the patient in this report had severe cachexia, hypovolemic shock, and heartworm infection, which all fell within the criteria of Virchow’s triad and were considered to have contributed simultaneously to thrombus formation. Furthermore, all of these clinical states that have a negative influence on both prognosis and mortality led to the need for CPN administration and central line placement. All of these numerous negative factors, the characteristics of CPN, and the long-term use of CPN contributed to the consequent cranial vena cava syndrome.
Protein-losing enteropathy is one of the factors influencing Virchow’s triad. Although not the sole cause of protein-losing enteropathy the loss of antithrombin contributes to hypercoagulability (4). Protein-losing enteropathy was not definitively diagnosed in this study, but clinical signs and laboratory findings supported its existence and, therefore, is a potential contraindication for central line placement. However, parenteral feeding via a central venous catheter was necessary because the patient had anorexia and cachexia. The condition of the patient presented a clinical dilemma in deciding the placement of the central line, which can be a further consideration for clinicians confronted with similar situations.
In a retrospective study by Reuter et al. (8), the overall mortality rate of patients who had received CPN was 48.8%. Among the 209 dogs included in this study, 5% had jugular thrombosis and a mortality rate of 50%. Furthermore, in two studies previously mentioned in this report, all patients were euthanized because of their debilitating state and complications. From the data obtained from these reports, clinicians should acknowledge that the status of a patient requiring CPN application is associated with mortality rate, and close monitoring is important.
Limitation of this case report is that its number of case is not enough to provide any solid opinion. The patient showed several signs associated with thrombus formation caused by CPN application and, thus, cranial vena cava syndrome; however, it is insufficient to say that CPN application was the sole cause. Additional studies with larger sample sizes are required to verify their association. Furthermore, coagulation profile was not performed during hospitalization. Anticoagulant and thrombolytic treatments were given only after diagnosis of clinical sign and ultrasound findings. Therefore it is hard to say that treatment strategy was optimal.
In conclusion, venous thrombus formation secondary to CPN application via the central line is a rare but possible complication. Veterinarians who are concerned about taking care of patients receiving CPN through the central line should keep the possibility of venous thrombus formation in mind. Patients with concurrent hypercoagulability disease or protein-related disease are at greater risk of thrombus formation.
This research was financially supported by the Ministry of Small and Medium-sized Enterprises (SMEs) and Startups (MSS), Korea, under the “Regional Specialized Industry Development Plus Program (R&D, S3244754)” supervised by the Korea Technology and Information Promotion Agency (TIPA).
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No.2020R1F1A1075219).
The authors have no conflicting interests.